Skip to main content
Top

International Journal of Clinical Oncology

Issue 1/2026

Content (17 Articles)

Japanese society for cancer of the colon and rectum (JSCCR) guidelines 2024 for the clinical practice of hereditary colorectal cancer

Kohji Tanakaya, Tatsuro Yamaguchi, Keiji Hirata, Masayoshi Yamada, Kensuke Kumamoto, Yasuki Akiyama, Kei Ishimaru, Koichi Okamoto, Yuko Kawasaki, Keigo Komine, Akira Sakamoto, Kunitoshi Shigeyasu, Yoshiko Shibata, Yusaku Shimamoto, Hideki Shimodaira, Shigeki Sekine, Akinari Takao, Misato Takao, Yasuyuki Takamizawa, Yoji Takeuchi, Noriko Tanabe, Fumitaka Taniguchi, Akiko Chino, Hourin Cho, Satoru Doi, Takeshi Nakajima, Sakiko Nakamori, Yoshiko Nakayama, Toshiya Nagasaki, Hisashi Hasumi, Kouji Banno, Takao Hinoi, Kenji Fujiyoshi, Takahiro Horimatsu, Kenta Masuda, Masashi Miguchi, Yusuke Mizuuchi, Yasuyuki Miyakura, Michihiro Mutoh, Takahiro Yoshioka, Shinji Tanaka, Kazuhiro Sakamoto, Kentaro Sakamaki, Michio Itabashi, Hideyuki Ishida, Naohiro Tomita, Kenichi Sugihara, Yoichi Ajioka

Supporting parents with cancer: a profile of patients using childcare services in a cancer center

Mayu Moriyasu, Makiko Ono, Natsue Uehiro, Ikuko Kamogawa, Maiko Ogasawara, Hiroki Kihara, Yaeko Miyagi, Akemi Kataoka, Toshimi Takano, Masayuki Watanabe

Prognostic impact of genomically matched therapy for solid cancers using real-world data from a provincial hospital in Japan

  • Original Article

Yoshinaga Okugawa, Takumi Fujiwara, Takahito Kitajima, Junya Tsuboi, Takeshi Sasaki, Yoshiki Okita, Masaki Ohi, Ryotaro Hashizume, Hiroshi Imai, Ikuyo Mochiki, Yasutaka Tono, Kanako Saito, Satoshi Tamaru, Takahiro Inoue, Toshiro Mizuno, Kaname Nakatani, Yuji Toiyama

Association of fat-free mass index and survival in patients with lung cancer: a multicenter cohort study

Gege Zhang, Hongxia Xu, Chuying Zhang, Saba Fida, Jiuwei Cui, Wei Li, Fuxiang Zhou, Chunling Zhou, Hanping Shi, Chunhua Song

Pooled safety analysis of pimitespib for the treatment of patients with advanced gastrointestinal stromal tumors

Yukinori Kurokawa, Noboru Yamamoto, Yuko Hirano, Naoki Arimura, Chunlan Sun, Toshihiko Doi

Prognostic stratification of recurrent colorectal liver metastasis: impact of recurrence-free interval, tumor numbers, and size on repeat liver resection

Hajime Kamiya, Shin Kobayashi, Masashi Kudo, Motokazu Sugimoto, Akihito Kawazoe, Hideaki Bando, Yuichiro Tsukada, Masaaki Ito, Takayuki Yoshino, Naoto Gotohda

Effect of Vonoprazan, potassium-competitive acid blocker, on Atezolizumab plus Bevacizumab efficacy in patients with hepatocellular carcinoma: a multicenter retrospective study

Masaya Takahashi, Katsuyuki Takahashi, Sawako Uchida-Kobayashi, Yuzuka Sasa, Hirotake Yamase, Daichiro Fujiwara, Tomohiro Yoshikawa, Yuika Komatsu, Masahito Shibano, Hiroki Arie, Tadafumi Hoshida, Yasuhiko Takata, Naoshi Odagiri, Hisakazu Matsumoto, Soichi Fumita, Toru Otori

Prognostic impact and site-specific efficacy of systemic therapies in locally advanced or metastatic urothelial carcinoma: in an era of expanding therapeutic options

Shoma Yamamoto, Minoru Kato, Taisuke Matsue, Nao Yukimatsu, Yuji Takeyama, Taiyo Otoshi, Takeshi Yamasaki, Katsuyuki Kuratsukuri, Junji Uchida

Comparison of first-line immuno-oncology combinations with molecular targeted therapy in patients with advanced renal cell carcinoma undergoing hemodialysis: a real-world multicenter retrospective study

Kosuke Ueda, Hiroki Kurata, Yoji Murakami, Akinori Minato, Masaki Shiota, Shotaro Nakanishi, Keijiro Kiyoshima, Toru Inoue, Hisaji Kumagae, Shinichiro Irie, Mitsuru Noguchi, Shuichi Tatarano, Hiroshi Matsuzaki, Yuji Tokuda, Atsuro Sawada, Tatsuro Abe, Yoshinori Oshiro, Shuji Harada, Tsukasa Igawa

Deubiquitinases as prognostic biomarker and potential drug target for gynecological cancers

Mavika Kondapally, Anubha Dey, Abhiram Matta, Harshitha Golagana, Shashi Kiran, Manjari Kiran

Prognostic impact of lymphadenectomy in patients with advanced ovarian clear cell carcinoma: an ancillary analysis of the JGOG3017-A4 study

Satoe Fujiwara, Muneaki Shimada, Yuri Ito, Yuji Takei, Takafumi Kuroda, Koji Nishino, Tatsuyuki Chiyoda, Yasuhisa Terao, Toru Sugiyama, Aikou Okamoto

Real-world multicenter study of immune checkpoint inhibitors in advanced cervical cancer across HPV-associated and HPV-independent subtypes

Kazuhiro Ko, Mayu Fukuda, Koji Yamanoi, Nobutaka Hayashi, Hisateru Yasui, Takuma Hayashi, Yoshihiro Yakushijin, Takehiko Tsumura, Atsushi Shirakawa, Chiho Nakashima, Yoshinori Imamura, Chikako Yamauchi, Toshio Shimizu, Takahito Ashihara, Nobuhiro Shibata, Takeshi Kotake, Aya Toyofuku, Taito Miyamoto, Rin Mizuno, Mana Taki, Ryusuke Murakami, Satoshi Morita, Manabu Muto, Masaki Mandai

Prognostic outcomes of immediate complete lymph node dissection versus observation in patients with acral melanoma of the sole with sentinel node metastasis: a retrospective, multicenter study

Sadao Inoue, Shigeru Koizumi, Naoya Yamazaki, Yuki Ichigozaki, Hiroshi Kitagawa, Yukiko Kiniwa, Sayuri Sato, Toshihiro Takai, Reiichi Doi, Takamichi Ito, Masahito Yasuda, Yutaka Kuwatsuka, Takeo Maekawa, Jun Asai, Takuya Miyagawa, Shigeto Matsushita, Takeru Funakoshi, Yosuke Yamamoto, Takashi Inozume, Akiko Kishi, Tatsuya Takenouchi, Hiraku Kokubu, Shusaku Ito, Yoshiyasu Umeda, Yuki Yamamoto, Shoichiro Ishizuki, Shiro Iino, Hiroshi Uchi, Tomoe Nakagawa, Kazuhiro Inafuku, Takahiro Haga, Takahide Kaneko, Masahiro Nakagawa, Hideki Kamiya, Masaru Arima, Toshihiko Hoashi, Azusa Hiura, Nobuo Kanazawa, Keiko Manabe, Masashi Ishikawa, Kenji Asagoe, Utsugi Iwasawa, Takafumi Kadono, Naohito Hatta, Shoichiro Minami, Eiji Nakano, Dai Ogata, Satoshi Fukushima, Hisashi Uhara, Kenta Nakama, Takaya Komori, Ken Igawa, Yasuhiro Nakamura

Comments on “Physical activity and risk of thyroid cancer: a systematic review and meta-analysis of prospective cohort studies”

Arun Kumar, Ankur Sharma, Saumya Das, Preeti Dnyandeo Sonje, Dhanya Dedeepya

Case simulations: Biomarker-driven management of NSCLC (Link opens in a new window)

Do you want to assess your biomarker testing skills and management decisions? Use these simulation-based case studies based on realistic NSCLC scenarios to do so in a practical and secure environment.

Independent Medical Education Grant:
  • Bayer HealthCare Pharmaceuticals Inc.
Learn more Link opens in a new window
COMMISSIONED

How-to guide for healthcare professionals: understanding genomic reports

This educational activity was initiated, funded and co-developed by Boehringer Ingelheim and is intended for healthcare professionals in the UK and Ireland only. 

Genomic testing helps inform cancer diagnosis, prognosis, and treatment. A genomic report is generated by the laboratory carrying out next-generation sequencing to analyze biopsy samples. Access this educational microsite to learn more about typical genomic report content and how to interpret test results for patients with cancer.

NP-GB-106631 | Jan 2026

Commissioned by:
  • Boehringer Ingelheim
Learn more
Image Credits
Biomarker-driven management of NSCLC logo/© Springer Health+ IME, DNA double helix structure on a purple background/© 2025 Adobe